Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin administration study for sports doping detection
ACTRN12608000237381Phase 4Completed
- Sponsor
- Concord Repatriation General Hospital
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin (2 arms), sponsored by Concord Repatriation General Hospital. Primary endpoint: Bioassay measurement of exogenous insulin levels in blood and urine. Started Oct 2007; status: completed.
02
Drugs
human insulin
Beyond the preview
Go deeper on ACTRN12608000237381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000237381.